James Del Rosso, DO: Discussing Early Immune Activity Upon Ruxolitinib Cream Withdrawal

Shanna Miranti, MPAS, PA-C: Assessing Treatment Efficacy in Patients with Vitiligo

Shanna Miranti, MPAS, PA-C, discusses the similar efficacy seen in patients treated with ruxolitinib at diagnosis versus those who had disease for years....

Shanna Miranti, MPAS, PA-C: Managing the Psychosocial Impact of Vitiligo

Shanna Miranti, MPAS, PA-C, discusses the bimodal distribution of vitiligo in male and female individuals and the necessary counseling for those who are managing their initial diagnosis....

Nada Elbuluk, MD: Connecting Patients with Vitiligo with Supportive Resources

Dr. Elbuluk discusses the importance of connecting patients with vitiligo to supportive resources for preventing and mitigating anxiety and depression related to the condition, especially socioeconomically disadvantaged patients who may not be aware of these resources in their community....

Nada Elbuluk, MD: New Research on Psychological Comorbidities in Patients with Vitiligo

Dr. Elbuluk discusses a recently published retrospective chart review that she and her colleagues published in the Archives of Dermatological Research, which included all patients diagnosed with vitiligo treated at a private hospital and a public hospital over a period of ten years, with a focus on associated psychiatric comorbidities. She summarizes the findings of rates of anxiety and depression in patients with vitiligo in terms of gender, race, and socioeconomic status....

Andrea Nguyen, PA-C, MS: Determining Treatment Goals and Expectations for Patients with Vitiligo

Andrea Nguyen discusses how she counsels patients with vitiligo and emphasizes the importance in communicating with patients about consistent application and dosing during a treatment regimen....

Raj Chovatiya, MD, PhD: Utilizing Ruxolitinib Cream for Patients with Vitiligo

Dr. Chovatiya discusses how to effectively treat patients with nonsegmental vitiligo using topical ruxolitinib cream and the importance in a slow and steady treatment regimen....

Nada Elbuluk, MD, FAAD: Research and Utility of Ruxolitinib Cream for Vitiligo

Dr. Elbuluk discusses results of the clinical trials for ruxolitinib cream in patients with vitiligo and how this treatment is being incorporated into the dermatologist’s vitiligo toolkit....

John Harris, MD, PhD: Effective Treatment for Patients with Vitiligo

John Harris, MD, PhD, Chair of Dermatology at UMass Chan Medical School, discusses the impact topical ruxolitinib cream has had on patients with vitiligo. He explains how this treatment has shown exceptional efficacy with limited side effects....

Susan Taylor, MD: The Impact of Vitiligo on Patients of Color

Susan Taylor, MD, Professor of Dermatology at The University of Pennsylvania in Philadelphia, Pennsylvania, reviews the burden of vitiligo on patients of color and reviews emerging topical and oral treatments to keep on the radar....

Nada Elbuluk, MD: Current and Future Treatment Options for Patients with Vitiligo

Nada Elbuluk, MD, a board certified dermatologist at the University of Southern California in Los Angeles, California, discusses the importance of offering a variety of treatment options to patients with vitiligo and tailoring these treatments to a patient’s specific needs....

John Harris, MD, PhD: The Evolution of Treatments for Vitiligo

John Harris, MD, PhD, Chair of Dermatology at Umass Chan Medical School, reviews the history of treatments for vitiligo, current treatments for vitiligo and their limitations, and exciting new treatments on the horizon for the condition....

Pearl Grimes, MD: The Psychological Impact of Vitiligo and Advancements in Treatment

Pearl Grimes, MD, Director of of Vitiligo and Pigmentation Institute of Southern California and Clinical Professor of Dermatology at UCLA discusses exciting advancements in therapy in hopes of finding JAK inhibitors that address stabilization, repigmentation and maintenance for vitiligo. In addition, Dr. Grimes reviews the emotional impact this disease has on patients....

EXPERT PERSPECTIVES IN VITILIGO

Experts in the field discuss new therapies and how they will impact the dermatologist's practice.